世界の心血管情報システム (CVIS) 市場： 2027 年までの予測

出版：Market Research Future（マーケットリサーチフューチャー）　出版年月：2022年10月

Global Cardiovascular Information System (CVIS) Market Research Report- Forecast till 2027
世界の心血管情報システム (CVIS) 市場調査レポート： 2027 年までの予測

レポート目次　　　　お問合せ・ご注文　　　　価格・納期について

Global Cardiovascular Information System (CVIS) Market Research Report- Forecast till 2027

System Market
Worldwide it has been noticed that the cardiovascular information system market possesses a USD 1,560.93 million during the conjecture time of 2020 to 2027. It has been denoted that the cardiovascular information system market projects at a CAGR of 8.23%. Everywhere, it has been found that because of cardiovascular sickness many individuals have passed on because of heart-related infections.
The significant market driving elements are the ascent in the need to join CVIS with CPAS/EMR and different modules connected with cardiology to build the cardiovascular information system market size. Driving elements like interoperability, getting to the remote pictures and information, and limiting the responsibility of the IT area from the online emergency clinic is assisting in growing the cardiovascular information system with marketing size. The reception of CVIS coordinated arrangements because of its huge purchasing force of well-known emergency clinics and facilities expands the size of the cardiovascular information system market in this end-client order.
Market Segmentation
Based on type, the cardiovascular information system market is separated into CVIS and C-PACS. The CVIS division involves a huge market share from estimated time of 2015 to 2020. The CVIS area examines the information well and empowers the specialists to complete the ideal choice in very little time. In view of sections, the market is separated into programming, administration, and equipment.
Innovation progression of innovation prompted the utilization of imaging strategies for the treatment of related messes. Cutting-edge innovation has assisted in unique announcing of the pictures in the cardiovascular information system with marketing which has helped in conveying the reports of the patients.
Regional Analysis
The cardiovascular information system market is extended to a great extent to the districts of North America coming after the European locale. Topographically, it has been denoted that this North American district is predominantly involved by severe protection and security guidelines and ascend in the extension of business in the cardiovascular information area. Universally, the North American locale has a medical services information system that has fostered its organization with merchants. Latin America is supposed to be somewhat in reverse than other arising nations yet is as yet encountering enormous potential for cardiovascular information system market development during the market figure period.
Major Players
The major market players of the global cardiovascular information system are GE, Koninklijke Philips N.V., McKesson Corporation, Siemens Healthineers, IBM Watson Health, Fujifilm Holdings Corporation, and Cerner Corporation.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

目次

LIST OF CONTENTS

1 EXECUTIVE SUMMARY 18

2 MARKET INTRODUCTION 19

2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 MARKET STRUCTURE 19

2.4 ASSUMPTIONS & LIMITATIONS 20

3 RESEARCH METHODOLOGY 21

3.1 DATA MINING 21

3.2 SECONDARY RESEARCH 22

3.3 PRIMARY RESEARCH 23

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 24

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 26

3.6.1 BOTTOM-UP APPROACH 27

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS 29

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES 30

4.2.2 GROWING GOVERNMENT INITIATIVES TOWARDS THE IMPLEMENTATION OF ELECTRONIC HEALTH RECORD SYSTEM 30

4.2.3 TECHNOLOGICAL ADVANCEMENTS 30

4.2.4 RISING DEMAND FOR DATA-DRIVEN TECHNOLOGIES 31

4.3 RESTRAINTS 32

4.3.1 HIGH COST OF CVIS FOLLOWED BY THE NEED FOR TRAINING 32

4.3.2 RESTRAINT IMPACT ANALYSIS 32

4.4 OPPORTUNITIES 32

4.4.1 EMERGING MARKETS OF CVIS 32

5 MARKET FACTOR ANALYSIS 33

5.1 VALUE CHAIN ANALYSIS 33

5.1.1 R&D 34

5.1.2 MANUFACTURING 34

5.1.3 DISTRIBUTION AND SALES 34

5.1.4 POST-SALES MONITORING 34

5.2 PORTER’S FIVE FORCES MODEL 35

5.2.1 BARGAINING POWER OF SUPPLIERS 35

5.2.2 BARGAINING POWER OF BUYERS 36

5.2.3 THREAT OF NEW ENTRANTS 36

5.2.4 THREAT OF SUBSTITUTES 36

5.2.5 INTENSITY OF RIVALRY 36

5.3 IMPACT OF COVID-19 ON THE CARDIOVASCULAR INFORMATION SYSTEM MARKET 36

5.3.1 OVERVIEW 36

5.3.2 IMPACT ON PRIVACY 37

5.3.3 IMPACT ON TECHNOLOGY 37

5.3.4 IMPACT ON DEMAND 37

6 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT 38

6.1 OVERVIEW 38

6.2 SOFTWARE 39

6.3 SERVICES 39

6.4 HARDWARE 40

7 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE 41

7.1 OVERVIEW 41

7.2 CLOUD-BASED/WEB-BASED 42

7.3 ON-PREMISE 42

8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION 43

8.1 OVERVIEW 43

8.2 CARDIAC AND PERIPHERAL CATHETERIZATION 44

8.3 ECHOCARDIOGRAPHY 45

8.4 HEMODYNAMICS MONITORING 45

8.5 ELECTROPHYSIOLOGY 46

8.6 VASCULAR ULTRASOUND 46

8.7 NUCLEAR CARDIOLOGY 47

8.8 ECG/STRESS/HOLTER MANAGEMENT 47

8.9 OTHERS 48

9 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER 49

9.1 OVERVIEW 49

9.2 HOSPITAL & CLINICS 50

9.3 DIAGNOSTIC LABORATORIES 50

9.4 CARDIAC CATH LABS 51

9.5 OTHERS 51

10 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION 52

10.1 OVERVIEW 52

10.2 AMERICAS 53

10.3 NORTH AMERICA 56

10.3.1 US 58

10.3.2 CANADA 59

10.3.3 LATIN AMERICA 61

10.4 EUROPE 63

10.4.1 WESTERN EUROPE 65

10.4.1.1 GERMANY 68

10.4.1.2 FRANCE 69

10.4.1.3 UK 71

10.4.1.4 ITALY 72

10.4.1.5 SPAIN 74

10.4.1.6 REST OF WESTERN EUROPE 76

10.4.2 EASTERN EUROPE 77

10.5 ASIA-PACIFIC 79

10.5.1 CHINA 81

10.5.2 INDIA 83

10.5.3 JAPAN 84

10.5.4 AUSTRALIA 86

10.5.5 SOUTH KOREA 87

10.5.6 REST OF ASIA-PACIFIC 89

10.6 MIDDLE EAST & AFRICA 90

10.6.1 MIDDLE EAST 93

10.6.2 AFRICA 94

11 COMPETITIVE LANDSCAPE 96

11.1 OVERVIEW 96

11.2 MAJOR PLAYERS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 96

11.3 COMPETITIVE BENCHMARKING 97

11.4 COMPETITOR DASHBOARD 98

11.5 DEVELOPMENTS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 98

11.5.1 ACQUISITION 98

11.5.2 COLLABORATION 99

11.5.3 PRODUCT LAUNCH 99

11.5.4 PARTNERSHIP 99

11.6 FINANCIAL MATRIX 100

12 COMPANY PROFILES 101

12.1 GE HEALTHCARE 101

12.1.1 COMPANY OVERVIEW 101

12.1.2 FINANCIAL OVERVIEW 102

12.1.3 PRODUCTS/SERVICES OFFERED 102

12.1.4 KEY DEVELOPMENTS 103

12.1.5 SWOT ANALYSIS 103

12.1.6 KEY STRATEGIES 103

12.2 SIEMENS HEALTHINEERS 104

12.2.1 COMPANY OVERVIEW 104

12.2.2 FINANCIAL OVERVIEW 105

12.2.3 PRODUCTS/SERVICES OFFERED 105

12.2.4 KEY DEVELOPMENTS 106

12.2.5 SWOT ANALYSIS 106

12.2.6 KEY STRATEGIES 106

12.3 KONINKLIJKE PHILIPS NV 107

12.3.1 COMPANY OVERVIEW 107

12.3.2 FINANCIAL OVERVIEW 108

12.3.3 PRODUCTS/SERVICES OFFERED 108

12.3.4 KEY DEVELOPMENTS 109

12.3.5 SWOT ANALYSIS 109

12.3.6 KEY STRATEGIES 109

12.4 FUJIFILM HOLDINGS CORPORATION 110

12.4.1 COMPANY OVERVIEW 110

12.4.2 FINANCIAL OVERVIEW 111

12.4.3 PRODUCTS/SERVICES OFFERED 111

12.4.4 KEY DEVELOPMENTS 112

12.4.5 SWOT ANALYSIS 112

12.4.6 KEY STRATEGIES 112

12.5 MCKESSON CORPORATION 113

12.5.1 COMPANY OVERVIEW 113

12.5.2 FINANCIAL OVERVIEW 114

12.5.3 PRODUCTS/SERVICES OFFERED 114

12.5.4 KEY DEVELOPMENTS 115

12.5.5 SWOT ANALYSIS 115

12.5.6 KEY STRATEGIES 116

12.6 CERNER CORPORATION 117

12.6.1 COMPANY OVERVIEW 117

12.6.2 FINANCIAL OVERVIEW 117

12.6.3 PRODUCTS OFFERED 118

12.6.4 KEY DEVELOPMENTS 118

12.6.5 SWOT ANALYSIS 119

12.6.6 KEY STRATEGIES 119

12.7 IBM WATSON HEALTH 120

12.7.1 COMPANY OVERVIEW 120

12.7.2 FINANCIAL OVERVIEW 121

12.7.3 PRODUCTS OFFERED 121

12.7.4 KEY DEVELOPMENTS 122

12.7.5 SWOT ANALYSIS 122

12.7.6 KEY STRATEGIES 123

12.8 LUMEDX 124

12.8.1 COMPANY OVERVIEW 124

12.8.2 FINANCIAL OVERVIEW 124

12.8.3 PRODUCTS OFFERED 124

12.8.4 KEY DEVELOPMENTS 124

12.8.5 SWOT ANALYSIS 125

12.8.6 KEY STRATEGIES 125

12.9 AGFA-GEVAERT N.V. 126

12.9.1 COMPANY OVERVIEW 126

12.9.2 FINANCIAL OVERVIEW 126

12.9.3 PRODUCTS OFFERED 126

12.9.4 KEY DEVELOPMENTS 127

12.9.5 SWOT ANALYSIS 127

12.9.6 KEY STRATEGIES 127

12.10 DIGISONICS INC. 128

12.10.1 COMPANY OVERVIEW 128

12.10.2 FINANCIAL OVERVIEW 128

12.10.3 PRODUCTS OFFERED 128

12.10.4 KEY DEVELOPMENTS 128

12.10.5 SWOT ANALYSIS 129

12.10.6 KEY STRATEGIES 129

12.11 CARESTREAM HEALTH 130

12.11.1 COMPANY OVERVIEW 130

12.11.2 FINANCIAL OVERVIEW 130

12.11.3 PRODUCTS/SERVICES OFFERED 130

12.11.4 KEY DEVELOPMENTS 130

12.11.5 SWOT ANALYSIS 131

12.11.6 KEY STRATEGIES 131

12.12 EPIC SYSTEMS CORPORATION 132

12.12.1 COMPANY OVERVIEW 132

12.12.2 FINANCIAL OVERVIEW 132

12.12.3 PRODUCTS OFFERED 132

12.12.4 KEY DEVELOPMENTS 132

12.12.5 SWOT ANALYSIS 133

12.12.6 KEY STRATEGIES 133

12.13 SCIMAGE, INC. 134

12.13.1 COMPANY OVERVIEW 134

12.13.2 FINANCIAL OVERVIEW 134

12.13.3 PRODUCTS/SERVICES OFFERED 134

12.13.4 KEY DEVELOPMENTS 134

12.13.5 SWOT ANALYSIS 135

12.13.6 KEY STRATEGIES 135

13 APPENDIX 136

13.1 REFERENCES 136

13.2 RELATED REPORTS 136

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 20

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

TABLE 3 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 39

TABLE 4 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR SOFTWARE, BY REGION, 2018–2027 (USD MILLION) 39

TABLE 5 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR SERVICES, BY REGION, 2018–2027 (USD MILLION) 39

TABLE 6 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR HARDWARE, BY REGION, 2018–2027 (USD MILLION) 40

TABLE 7 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 42

TABLE 8 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET FOR CLOUD-BASED/WEB-BASED, BY REGION, 2018–2027 (USD MILLION) 42

TABLE 9 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR ON-PREMISE, BY REGION, 2018–2027 (USD MILLION) 42

TABLE 10 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 44

TABLE 11 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET FOR CARDIAC AND PERIPHERAL CATHETERIZATION, BY REGION, 2018–2027 (USD MILLION) 44

TABLE 12 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR ECHOCARDIOGRAPHY, BY REGION, 2018–2027 (USD MILLION) 45

TABLE 13 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR HEMODYNAMICS MONITORING, BY REGION, 2018–2027 (USD MILLION) 45

TABLE 14 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR ELECTROPHYSIOLOGY, BY REGION, 2018–2027 (USD MILLION) 46

TABLE 15 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR VASCULAR ULTRASOUND, BY REGION, 2018–2027 (USD MILLION) 46

TABLE 16 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR NUCLEAR CARDIOLOGY, BY REGION, 2018–2027 (USD MILLION) 47

TABLE 17 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR ECG/STRESS/HOLTER MANAGEMENT, BY REGION, 2018–2027 (USD MILLION) 47

TABLE 18 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 48

TABLE 19 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 50

TABLE 20 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET FOR HOSPITAL & CLINICS, BY REGION, 2018–2027 (USD MILLION) 50

TABLE 21 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR DIAGNOSTIC LABORATORIES, BY REGION, 2018–2027 (USD MILLION) 50

TABLE 22 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR CARDIAC CATH LABS, BY REGION, 2018–2027 (USD MILLION) 51

TABLE 23 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION) 51

TABLE 24 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION, 2018–2027 (USD MILLION) 52

TABLE 25 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION, 2018–2027, (USD MILLION) 54

TABLE 26 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 54

TABLE 27 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 54

TABLE 28 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 55

TABLE 29 AMERICAS: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 55

TABLE 30 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COUNTRY, 2018–2027, (USD MILLION) 56

TABLE 31 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 56

TABLE 32 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 57

TABLE 33 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 57

TABLE 34 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 57

TABLE 35 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 58

TABLE 36 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 58

TABLE 37 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 58

TABLE 38 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 59

TABLE 39 CANADA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 59

TABLE 40 US: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 59

TABLE 41 CANADA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 60

TABLE 42 CANADA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 60

TABLE 43 LATIN AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 61

TABLE 44 LATIN AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 61

TABLE 45 LATIN AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 61

TABLE 46 LATIN AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 62

TABLE 47 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION, 2018–2027 (USD MILLION) 63

TABLE 48 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 64

TABLE 49 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 64

TABLE 50 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 64

TABLE 51 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 65

TABLE 52 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COUNTRY, 2018–2027, (USD MILLION) 65

TABLE 53 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 66

TABLE 54 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 66

TABLE 55 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 67

TABLE 56 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 67

TABLE 57 GERMANY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 68

TABLE 58 GERMANY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 68

TABLE 59 GERMANY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 68

TABLE 60 GERMANY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 69

TABLE 61 FRANCE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 69

TABLE 62 FRANCE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 69

TABLE 63 FRANCE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 70

TABLE 64 FRANCE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 70

TABLE 65 UK: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 71

TABLE 66 UK: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 71

TABLE 67 UK: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 71

TABLE 68 UK: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 72

TABLE 69 ITALY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 72

TABLE 70 ITALY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 72

TABLE 71 ITALY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 73

TABLE 72 ITALY: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 73

TABLE 73 SPAIN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 74

TABLE 74 SPAIN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 74

TABLE 75 SPAIN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 75

TABLE 76 SPAIN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 75

TABLE 77 REST OF WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 76

TABLE 78 REST OF WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 76

TABLE 79 REST OF WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 76

TABLE 80 REST OF WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 77

TABLE 81 EASTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 77

TABLE 82 EASTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 77

TABLE 83 EASTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 78

TABLE 84 EASTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 78

TABLE 85 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COUNTRY, 2018–2027, (USD MILLION) 79

TABLE 86 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 80

TABLE 87 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 80

TABLE 88 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 80

TABLE 89 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 81

TABLE 90 CHINA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 81

TABLE 91 CHINA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 81

TABLE 92 CHINA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 82

TABLE 93 CHINA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 82

TABLE 94 INDIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 83

TABLE 95 INDIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 83

TABLE 96 INDIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 83

TABLE 97 INDIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 84

TABLE 98 JAPAN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 84

TABLE 99 JAPAN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 84

TABLE 100 JAPAN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 85

TABLE 101 JAPAN: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 85

TABLE 102 AUSTRALIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 86

TABLE 103 AUSTRALIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 86

TABLE 104 AUSTRALIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 86

TABLE 105 AUSTRALIA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 87

TABLE 106 SOUTH KOREA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 87

TABLE 107 SOUTH KOREA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 87

TABLE 108 SOUTH KOREA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 88

TABLE 109 SOUTH KOREA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027, (USD MILLION) 88

TABLE 110 REST OF ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 89

TABLE 111 REST OF ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 89

TABLE 112 REST OF ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 89

TABLE 113 REST OF ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 90

TABLE 114 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION, 2018–2027 (USD MILLION) 90

TABLE 115 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027 (USD MILLION) 91

TABLE 116 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 91

TABLE 117 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 92

TABLE 118 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 92

TABLE 119 MIDDLE EAST: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 93

TABLE 120 MIDDLE EAST: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027 (USD MILLION) 93

TABLE 121 MIDDLE EAST: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027 (USD MILLION) 93

TABLE 122 MIDDLE EAST: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 94

TABLE 123 AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2018–2027, (USD MILLION) 94

TABLE 124 AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2018–2027, (USD MILLION) 94

TABLE 125 AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2018–2027, (USD MILLION) 95

TABLE 126 AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2018–2027 (USD MILLION) 95

TABLE 127 MAJOR PLAYERS IN THE GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 96

TABLE 128 COMPETITOR DASHBOARD: GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 98

TABLE 129 ACQUISITION 98

TABLE 130 COLLABORATION 99

TABLE 131 PRODUCT LAUNCH 99

TABLE 132 PARTNERSHIP 99

TABLE 133 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED 102

TABLE 134 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED 105

TABLE 135 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS 106

TABLE 136 KONINKLIJKE PHILIPS NV: PRODUCTS/SERVICES OFFERED 108

TABLE 137 KONINKLIJKE PHILIPS NV: KEY DEVELOPMENTS 109

TABLE 138 FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SERVICES OFFERED 111

TABLE 139 MCKESSON CORPORATION: PRODUCTS/SERVICES OFFERED 114

TABLE 140 CERNER CORPORATION: PRODUCTS OFFERED 118

TABLE 141 CERNER CORPORATION: KEY DEVELOPMENTS 118

TABLE 142 IBM WATSON HEALTH: PRODUCTS OFFERED 121

TABLE 143 IBM WATSON HEALTH: KEY DEVELOPMENTS 122

TABLE 144 LUMEDX: PRODUCTS OFFERED 124

TABLE 145 LUMEDX: KEY DEVELOPMENTS 124

TABLE 146 AGFA-GEVAERT N.V.: PRODUCTS OFFERED 126

TABLE 147 DIGISONICS INC.: PRODUCTS OFFERED 128

TABLE 148 CARESTREAM HEALTH: PRODUCTS/SERVICES OFFERED 130

TABLE 149 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED 132

TABLE 150 SCIMAGE, INC.: PRODUCTS/SERVICES OFFERED 134

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS 18

FIGURE 2 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM (CVIS) INDUSTRY MARKET 19

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 26

FIGURE 4 MARKET DYNAMICS: CARDIOVASCULAR INFORMATION SYSTEM MARKET 29

FIGURE 5 DRIVER IMPACT ANALYSIS 31

FIGURE 6 VALUE CHAIN ANALYSIS: GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET 33

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: CARDIOVASCULAR INFORMATION SYSTEM MARKET 35

FIGURE 8 GLOBAL CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY COMPONENT, 2020 & 2027, (USD MILLION) 38

FIGURE 9 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY DELIVERY MODE, 2020 & 2027, (USD MILLION) 41

FIGURE 10 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY APPLICATION, 2020 & 2027, (USD MILLION) 43

FIGURE 11 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY END USER, 2020 & 2027 (USD MILLION) 49

FIGURE 12 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET, BY REGION 2020 & 2027 (USD MILLION) 52

FIGURE 13 GLOBAL: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY REGION, 2020 53

FIGURE 14 NORTH AMERICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY COUNTRY, 2020 56

FIGURE 15 EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY REGION, 2020 63

FIGURE 16 WESTERN EUROPE: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY COUNTRY, 2020 66

FIGURE 17 ASIA-PACIFIC: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY COUNTRY, 2020 79

FIGURE 18 MIDDLE EAST & AFRICA: CARDIOVASCULAR INFORMATION SYSTEM MARKET SHARE (%), BY REGION, 2020 91

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS 97

FIGURE 20 SALES & OPERATING INCOME, 2020 100

FIGURE 21 R&D EXPENDITURE, 2020 100

FIGURE 22 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 102

FIGURE 23 GE HEALTHCARE: SWOT ANALYSIS 103

FIGURE 24 SIEMENS HEALTHINEERS: FINANCIAL OVERVIEW SNAPSHOT 105

FIGURE 25 SIEMENS HEALTHINEERS: SWOT ANALYSIS 106

FIGURE 26 KONINKLIJKE PHILIPS NV: FINANCIAL OVERVIEW SNAPSHOT 108

FIGURE 27 KONINKLIJKE PHILIPS NV: SWOT ANALYSIS 109

FIGURE 28 FUJIFILM HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 111

FIGURE 29 FUJIFILM HOLDINGS CORPORATION: SWOT ANALYSIS 112

FIGURE 30 MCKESSON CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 114

FIGURE 31 MCKESSON CORPORATION: SWOT ANALYSIS 115

FIGURE 32 CERNER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 117

FIGURE 33 CERNER CORPORATION: SWOT ANALYSIS 119

FIGURE 34 IBM WATSON HEALTH: FINANCIAL OVERVIEW SNAPSHOT 121

FIGURE 35 IBM WATSON HEALTH: SWOT ANALYSIS 122

FIGURE 36 LUMEDX: SWOT ANALYSIS 125

FIGURE 37 AGFA-GEVAERT N.V.: FINANCIAL OVERVIEW SNAPSHOT 126

FIGURE 38 AGFA-GEVAERT N.V.: SWOT ANALYSIS 127

FIGURE 39 DIGISONICS INC.: SWOT ANALYSIS 129

FIGURE 40 CARESTREAM HEALTH: SWOT ANALYSIS 131

FIGURE 41 EPIC SYSTEMS CORPORATION: SWOT ANALYSIS 133

FIGURE 42 SCIMAGE, INC.: SWOT ANALYSIS 135